Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Venture Funding Deals: Korean D&D Raises $137.1m For Subsidiary Model

Sep 11 2019

• By Deanna Kamienski, Beth Allan, and Maureen Riordan

Venture Funding Reg column image

Related Content

Oncorus Raises $79.5m To Take Its First Oncolytic Virus Into The Clinic

Aug 21 2019

Finance Watch: Chinook Debuts With $65m For Precision Kidney Disease Medicines

Aug 22 2019

Finance Watch: Landos Raises $60m Series B Round Ahead Of Phase II Data In 2020

Aug 14 2019

Related Companies

Amolyt Pharma

D&D Pharmatech

Neuraly, Inc.

Finch Therapeutics Group, Inc.

Graybug Vision, Inc.

Landos Biopharma, Inc.

MetaVia Inc.

Gemphire Therapeutics, Inc.

Harvard University

Dong-A Socio Holdings

Oncorus, Inc.

Bristol Myers Squibb Company

ORIC Pharmaceuticals, Inc.

Memorial Sloan Kettering Cancer Center

Renovacor Inc.

Temple University

Additional Topics

Deals Financing StartUps and SMEs Business Strategies Commercial BioPharmaceutical

More from Deals

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window